Huadong Medicine Co., Ltd's latest marketcap:
As of 06/18/2025, Huadong Medicine Co., Ltd's market capitalization has reached $10.2 B. According to our data, Huadong Medicine Co., Ltd is the 1872th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 10.2 B |
| Revenue (ttm) | 5.87 B |
| Net Income (ttm) | 495.81 M |
| Shares Out | 1.75 B |
| EPS (ttm) | 0.28 |
| Forward PE | 17.14 |
| Ex-Dividend Date | 06/05/2025 |
| Earnings Date | 08/15/2025 |
Huadong Medicine Co., Ltd's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/18/2025 | ¥10.2 B | 26.23% | 1872 |
| 12/31/2024 | ¥60.55 B | -16.55% | 2007 |
| 12/29/2023 | ¥72.56 B | -11.6% | 1577 |
| 12/30/2022 | ¥82.09 B | 16.7% | 1312 |
| 12/31/2021 | ¥70.34 B | 51.36% | 1667 |
| 12/31/2020 | ¥46.47 B | 8.94% | 2136 |
| 12/31/2019 | ¥42.66 B | 10.57% | 2030 |
| 12/28/2018 | ¥38.58 B | -26.34% | 1833 |
| 12/29/2017 | ¥52.38 B | 49.52% | 1577 |
| 12/30/2016 | ¥35.03 B | -1.53% | 1925 |
Company Profile
About Huadong Medicine Co., Ltd.
Huadong Medicine Co., Ltd. is a leading pharmaceutical company engaged in the wholesale and retail of pharmaceutical products across China and internationally. Headquartered in Hangzhou, China, the company was established in 1993 and operates through diversified segments.
Business Segments
- Pharmaceutical Industry: Manufactures and sells antibiotics, Chinese patent medicines, synthetic drugs, and genetic engineering drugs.
- Pharmaceutical Business: Distributes Chinese and western medicines, herbal medicines, medical instruments, and specialized drugs including immunosuppressive agents, antineoplastic drugs, and cardiovascular medications.
- Aesthetic Medicine: Provides products and solutions in the medical beauty field.
- Industrial Microbiology: Engages in pharmaceutical logistics and microbial-related activities.
Key Offerings
- Pharmaceutical distribution (antibiotics, endocrine drugs, digestive system drugs, etc.)
- Medical apparatus and equipment
- Business, leasing, and warehousing services
Strategic Collaboration
The company has partnered with SynerK PharmaTech (Suzhou) Co., Ltd. to develop SNK-2726, a small nucleic acid (siRNA) drug targeting hypertension through angiotensinogen (AGT) inhibition.
Frequently Asked Questions
-
What is Huadong Medicine Co., Ltd's (SHE-000963) current market cap?As of 06/18/2025, Huadong Medicine Co., Ltd (including the parent company, if applicable) has an estimated market capitalization of $10.2 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Huadong Medicine Co., Ltd (SHE-000963) rank globally by market cap?Huadong Medicine Co., Ltd global market capitalization ranking is approximately 1872 as of 06/18/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.